Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Aramchol | Aramchol Glycine Conjugate | VL6800002 | View |
Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Aramchol | Aramchol Glycine Conjugate | VL6800002 | View |
[rfq_list]
Catalogue No. | VL6800002 |
CAS No. | N/A |
Molecular Formula | C46H82N2O6 |
Molecular Weight | 759.15 g/mol |
Parent drug | Aramchol |
IUPAC Name | 2-((R)-4-((3S, 5S, 7R, 8R, 9S, 10S, 12S, 13R, 14S, 17R)-7, 12-dihydroxy-3-icosanamido-10, 13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)acetic acid |
Synonyms | N/A |
References | Sumida, Yoshio, and Masashi Yoneda. “Current and Future Pharmacological Therapies for NAFLD/NASH.” Journal of Gastroenterology, vol. 53, no. 3, Dec. 2017, pp. 362–76, https://doi.org/10.1007/s00535-017-1415-1. |
Status | In-stock |
ListName | Aramchol Glycine Conjugate |
Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields